Analyst Predicts $20bn COVID Vaccines Market In 2021
Pfizer Expected To Take Early Lead
Analysts have taken a first stab at predicting the size of the COVID-19 vaccine market – in which Pfizer and Moderna are likely to start strong, but could give way to other big players.
You may also be interested in...
Initial results from the study are expected in early December 2020, which would allow the start of a Phase III trial before the end of the year.
The UK biotech looks to have reached the end of the road, despite some encouraging signs from its microbiome-based pipeline.
CEO Vas Narasimhan wants the company to be more agile and identify more blockbuster opportunities.